Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|June 22, 2017
PlGF enhances TLR-dependent inflammatory responses in human mononuclear phagocytesLaura F Newell, Shernan G Holtan, Jane E Yates, et al.
Scientific Reports|October 6, 2020
Diurnal stability of cell-free DNA and cell-free RNA in human plasma samplesJosiah T Wagner, Hyun Ji Kim, Katie C Johnson-Camacho, et al.
Blood Vessels, Thrombosis & Hemostasis|June 12, 2025
Vascular biomarkers reveal a unique toxicity profile of posttransplant cyclophosphamide: secondary analysis of BMT CTN 0402 and 1202Laura F Newell, Najla El Jurdi, Brian C Betts, et al.
Differentiation; Research in Biological Diversity|November 21, 2007
Complementary roles for histone deacetylases 1, 2, and 3 in differentiation of pluripotent stem cellsGlen W Humphrey, Yong-Hong Wang, Tazuko Hirai, et al.
Stem Cells Translational Medicine|August 29, 2013
Dissection of the human multipotent adult progenitor cell secretome by proteomic analysisGregory G Burrows, Wouter Van't Hof, Laura F Newell, et al.
Cytotherapy|February 20, 2026
Impact of ABO compatibility on outcomes after allogeneic hematopoietic cell transplantation (HCT): increased risk of acute GVHD with ABO bidirectional mismatch, independent of traditional and emerging GVHD prophylaxis strategiesYun Yu, Mikayla K Murphy, Virginia Tan, et al.
Cancers|March 13, 2024
CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 TrialScott R Solomon, Bayard L Powell, Jamie Koprivnikar, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2019
A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemiasTara L Lin, Laura F Newell, Robert K Stuart, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2019
Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell TransplantationLaura F Newell, Todd E DeFor, Corey Cutler, et al.
BMC Hematology|September 16, 2014
Impact of clinical factors and allograft leukocyte content on post-transplant lymphopenia, monocytopenia, and survival in patients undergoing allogeneic peripheral blood haematopoietic cell transplantMary D Thoma, Jennifer Glejf, Eapen Jacob, et al.
Pageof 4